Skip to main content

Relmada Therapeutics, Inc.

RLMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001553643

In the last 90 days, Relmada Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $693.7M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Relmada Therapeutics, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of RLMD: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders9588−7
Shares16.1M15.0M−1.11M (−6.9%)
Value$39.7M$45.0M+$5.35M (+13.5%)

New holders (7)

Institutions that held Relmada Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to RLMD in Q3 2023
InstitutionSharesValue% of portfolio
Jacobs Levy Equity Management, Inc125,846$377.5K0.00%
Schonfeld Strategic Advisors LLC109,310$327.9K0.00%
Silverarc Capital Management, LLC100,000$300.0K0.11%
Opaleye Management Inc.30,000$90.0K0.03%
Stratos Wealth Partners, LTD.16,000$48.0K0.00%
LPL Financial LLC12,960$38.9K0.00%
Bedel Financial Consulting Inc10,000$30.0K0.01%

Sold out (14)

Institutions that held Relmada Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of RLMD in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Old Mission Capital LLC45,099$110.9K
Y-Intercept (Hong Kong) Ltd42,574$104.7K
Ergoteles LLC27,100$66.7K
Cubist Systematic Strategies, LLC15,477$38.1K
HRT Financial LP14,840$36.0K
Boothbay Fund Management, LLC12,792$31.5K
Jane Street Group, LLC12,118$29.8K
Los Angeles Capital Management LLC11,877$29.2K
XTX Topco Ltd10,767$26.5K
Point72 Asset Management, L.P.4,703$11.6K
Point72 Middle East FZE2,313$5.69K
Red Tortoise LLC690$1.70K
New York State Common Retirement Fund192$472
The PNC Financial Services Group, Inc.98$241